Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties

This publication has 23 references indexed in Scilit:

• CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats
  American Journal of Physiology-Endocrinology and Metabolism, 2007
• The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats
  Behavioural Pharmacology, 2003
• Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice
  European Journal of Pharmacology, 2003
• Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea
  Psychopharmacology, 2003
• Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by Δ9-THC and other cannabinoids
  Pharmacology Biochemistry and Behavior, 2002
• Effect of Chronic Administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone Mesylate (WIN55,212-2) or Δ9-Tetrahydrocannabinol on Cannabinoid Receptor Adaptation in Mice
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeys
  European Journal of Pharmacology, 2001
• Inverse agonists and neutral antagonists at µ opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence
  Journal of Neurochemistry, 2001
• Inhibitory effects of SR141716A on G-protein activation in rat brain
  European Journal of Pharmacology, 2001
• Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB1 cannabinoid receptor
  Biochemical Pharmacology, 2000